HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Standardised assessment of membrane proteinase 3 expression. Analysis in ANCA-associated vasculitis and controls.

AbstractOBJECTIVES:
Increased numbers of neutrophils expressing proteinase 3 on their membrane (mPR3) have been reported in anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV) and are suggested to be involved in AAV immunopathogenesis. In most studies, neutrophils were analysed for mPR3 expression without priming with TNFalpha, suggesting that mPR3 expression on neutrophils is dependent on other priming events, such as isolation procedures . These priming events can be variable. Therefore, we analysed mPR3 expression on neutrophils before and after priming with TNFalpha to assess whether standardised assessment of mPR3 expression requires priming. Using neutrophils before and after priming with TNFalpha, we assessed percentages of mPR3(+) neutrophils in patients with AAV and in disease and healthy controls.
METHODS:
Neutrophils from patients with PR3-AAV and MPO-AAV, systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), and from healthy controls were analysed before and after priming with TNFalpha for mPR3 expression.
RESULTS:
42% of all individuals analysed showed minimal expression for mPR3 on all neutrophils before priming with TNFalpha, whereas after priming a clear mPR3(+) subset was observed next to mPR3(-) neutrophils, corresponding to bimodal mPR3 expression. In patients with PR3-AAV or MPO-AAV, the percentage of mPR3(+) neutrophils after priming with TNFalpha was significantly increased (p<0.01 and p<0.05, respectively) compared with healthy controls. Percentages of mPR3(+) PMN were also increased in patients with SLE (p<0.01) but not in RA.
CONCLUSION:
Standardised assessment of proteinase 3 on the membrane of neutrophils requires priming with TNFalpha. Percentages of mPR3(+) PMN are increased in AAV and SLE, but not in RA.
AuthorsAndré P van Rossum, Minke G Huitema, Coen A Stegeman, Marc Bijl, Karina de Leeuw, Miek A Van Leeuwen, Pieter C Limburg, Cees G M Kallenberg
JournalAnnals of the rheumatic diseases (Ann Rheum Dis) Vol. 66 Issue 10 Pg. 1350-5 (Oct 2007) ISSN: 0003-4967 [Print] England
PMID17446240 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Antineutrophil Cytoplasmic
  • Biomarkers
  • Receptors, Complement 3b
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Peroxidase
  • Myeloblastin
Topics
  • Adult
  • Antibodies, Antineutrophil Cytoplasmic (immunology)
  • Arthritis, Rheumatoid (enzymology, immunology)
  • Biomarkers (analysis)
  • Cell Membrane (enzymology, immunology)
  • Female
  • Humans
  • Lupus Erythematosus, Systemic (enzymology, immunology)
  • Male
  • Middle Aged
  • Myeloblastin (analysis)
  • Neutrophil Activation (immunology)
  • Neutrophils (enzymology, immunology)
  • Peroxidase (immunology)
  • Receptors, Complement 3b (analysis)
  • Receptors, Tumor Necrosis Factor (analysis)
  • Tumor Necrosis Factor-alpha (immunology)
  • Vasculitis (enzymology, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: